Mason Technology to Launch Evident SLIDEVIEW™ DX VS200 in Ireland – Now CE-IVDR Certified
Mason Technology, the exclusive distributor of Evident imaging solutions in Ireland, will launch the SLIDEVIEW™ DX VS200 Universal Whole Slide Imaging Scanner in July 2025. Now CE-marked under the European Union In Vitro Diagnostic Medical Devices Regulation (IVDR 2017/746), the system meets the latest standards for clinical diagnostic use.
The SLIDEVIEW DX VS200 delivers high-resolution, high-throughput imaging for a wide range of pathology applications. It combines top-tier image quality, trusted optical engineering, and upgrade flexibility. As a result, clinical labs can rely on it for both current workflows and future diagnostic needs.
Confidence for Every Case
Evident built the SLIDEVIEW DX VS200 on over 100 years of expertise in precision optics. It captures high-quality images across multiple magnifications and slide formats. Users can choose from five imaging modes: brightfield, polarisation, fluorescence, darkfield, and phase contrast.
Key features include:
-
CE-marked under EU IVDR 2017/746 for clinical use in Europe
-
High-throughput scanning with high-resolution results
-
Five imaging modes: brightfield, fluorescence, polarisation, darkfield, and phase contrast
-
Up to 100× magnification, including oil-immersion objectives
-
SILA optical sectioning for improved clarity in thick or fixed tissue
-
TruAI™ deep-learning segmentation for advanced image analysis
-
Integration with LIS and image management systems (DICOM, HL7, FHIR)
Vice President of the Digital Pathology Business at Evident, Dr Tina Manoharan, commented:
“Introducing the quality and versatility of the SLIDEVIEW DX VS200 whole slide imaging scanner to diagnostic use cases with the CE marking under the EU IVDR is a significant milestone for Evident and for our customers throughout Europe.
This designation underscores our commitment to advancing digital pathology and supporting laboratories with compliant, high-performance imaging solutions.”
Supporting Clinical Pathology in Ireland
Sales Manager at Mason Technology Gordon Wright added:
“The CE-IVDR certification represents a significant milestone, as it ensures that the SLIDEVIEW DX VS200 meets the highest level of regulatory compliance now required within the EU. For clinical laboratories in Ireland, this is about more than just performance – it is about trust, traceability, and future-readiness.
This system combines Evident’s world-class imaging with intelligent automation and seamless digital integration. Whether it is used in a pathology lab or research setting linked to diagnostics, the SLIDEVIEW DX VS200 offers confidence, flexibility, and long-term value.”
Onsite Demos Available This Autumn
We are bringing the power and performance of the Evident SLIDEVIEW™ DX VS200 directly to clinical and research teams across Ireland this October and November as part of a nationwide, interest-led roadshow. For more information, visit: SLIDEVIEW VS200 for Digital Pathology or contact Mason Technology directly using the form below.
Disclaimer:
Polarization, fluorescence, darkfield, phase contrast, TruAI, and DICOM: This product is intended for Laboratory Use. It is the customer’s responsibility to ensure that the performance of the product is suitable for the customer’s specific use or application. For further questions about available options and configurations in your region, please contact your local Evident representative.
SLIDEVIEW is a trademark of Evident Corporation or its subsidiaries.
RECENT POST
-
Statistical Process Control for Filling and Packaging...
May 25, 2026
Blog -
Net Content Compliance and Overfill Control in Manufact...
May 05, 2026
Blog -
Building Trust with Legal-for-Trade DWS Systems
May 05, 2026
Blog -
Mason Technology Appointed to HSE National Framework fo...
Apr 27, 2026
News -
Microscopy Technical Training Series
Apr 22, 2026
Videos -
Mason Technology Partners with Azenta Life Sciences to ...
Apr 21, 2026
News -
Digital Recipe Control and Production Weighing in Bakin...
Apr 16, 2026
Blog -
Reduce Downtime and Audit Risk in Your Clinical Laborat...
Apr 15, 2026
Blog
